SUMMARY
Subjects of the pharmaceutical industry (SPI) usually function in the conditions of uncertainty and dynamic environment. Pharmacy is characterized by logistic risks due to specific properties of drugs, active pharmaceutical ingredients and active substances.The aim of the research is substantiation of logistic risk significance affecting the quality of drugs, and development of the mechanism for their minimization. The research results were based on the use of methods of expert assessment, ascent from the general to the special, the relationship of qualitative and quantitative characteristics. The logistic risk in the pharmaceutical industry is an event that results in losses of SPI or makes the possibility of an adverse situation or irrelevant results related to flows within the pharmaceutical logistic chain when changing external and internal factors. Availability of a great number of logistic risks makes it necessary to reduce risk of the SPI logistic activity, and, consequently, to develop the risk management mechanism. The algorithm of the logistic risk management of SPI includes seven steps. At the first stage the analysis of SPI logistic operations is conducted, at the second stage their logistic risks and causes are analyzed. Based on this analysis the data sampling that characterize the logistic activity results of SPI is formed. At the third stage, there is quantitative and qualitative assessment of the logistic risks identified in the previous step. At the fourth stage the effect of the internal and external factors on the logistic riskis analyzed. Based on the previous analysis during the fifth stage the scenarios of development of the situation are developed in relation to the threat of the origin of certain logistic risk and the methods of estimation of logistic risks are selected. At the sixth stage logistic risk is estimated. Based on the previous analysis the necessity of calculation of the integral logistic risk is reasonable.